Literature DB >> 7554871

5-year prospective, naturalistic follow-up study of panic disorder.

C Faravelli1, S Paterniti, A Scarpato.   

Abstract

Ninety-nine patients with panic disorder (PD) not comorbid with other psychiatric disorders were evaluated for 5 years using a naturalistic prospective design. The probability of achieving full remission, albeit transitory, was 37.5%, whereas 72.8% of cases showed a consistent amelioration. However, among patients with an initial positive outcome, the probability of remaining well was 41.4% after 5 years. When the general course of the disorder during the follow-up period was considered, only 12.12% of the subjects had a complete and stable remission of symptoms, whereas 47.47% had a generally positive but not fully satisfactory amelioration either due to infrequent recurrences of the illness or to chronic continuation of symptoms at a mild level. On the other hand, 40.40% of the subjects reported an overall poor outcome because of the presence of a recurrent pattern of illness (11.11%) or because the periods of well-being did not represent more than 40% of the time being considered (29.29%). Among the predictors taken into consideration, only duration of illness before intake showed a strict relationship with long-term outcome, with patients having a lesser duration of illness at the moment of the index episode showing a significantly better outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7554871     DOI: 10.1016/s0010-440x(95)90072-1

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  5 in total

1.  Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.

Authors:  Steven E Bruce; Kimberly A Yonkers; Michael W Otto; Jane L Eisen; Risa B Weisberg; Maria Pagano; M Tracie Shea; Martin B Keller
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

2.  Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication II: associations with persistence of DSM-IV disorders.

Authors:  Katie A McLaughlin; Jennifer Greif Green; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Ronald C Kessler
Journal:  Arch Gen Psychiatry       Date:  2010-02

3.  Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder.

Authors:  Denise A Chavira; Murray B Stein; Daniela Golinelli; Cathy D Sherbourne; Michelle G Craske; Greer Sullivan; Alexander Bystritsky; Peter P Roy-Byrne
Journal:  J Nerv Ment Dis       Date:  2009-10       Impact factor: 2.254

Review 4.  Diagnosis and treatment of agoraphobia with panic disorder.

Authors:  Giulio Perugi; Franco Frare; Cristina Toni
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 5.  Biological predictors of pharmacological therapy in anxiety disorders.

Authors:  Eduard Maron; David Nutt
Journal:  Dialogues Clin Neurosci       Date:  2015-09       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.